Showing results (51-60 of 504) with videos related to
Sort By:
Pageof 51
Targeted Oncology|August 4, 2010
Targeted therapies for non-clear renal cell carcinomaEric A Singer, Gennady Bratslavsky, W Marston Linehan, et al.Urologic Oncology|March 17, 2009
The clinical implications of the genetics of renal cell carcinomaInger Rosner, Gennady Bratslavsky, Peter A Pinto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of diseaseRamaprasad Srinivasan, Christopher J Ricketts, Carole Sourbier, et al.Journal of the National Cancer Institute|November 15, 2012
Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCNHisashi Hasumi, Masaya Baba, Yukiko Hasumi, et al.Cancer|April 30, 2009
Hereditary kidney cancer: unique opportunity for disease-based therapyW Marston Linehan, Peter A Pinto, Gennady Bratslavsky, et al.Familial Cancer|May 25, 2013
Diagnosis and management of BHD-associated kidney cancerLambros Stamatakis, Adam R Metwalli, Lindsay A Middelton, et al.Cancer|November 14, 2012
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristicsWong-Ho Chow, Brian Shuch, W Marston Linehan, et al.Genes, Chromosomes & Cancer|March 18, 2011
Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndromeJihane N Benhammou, Cathy D Vocke, Avni Santani, et al.Head and Neck Pathology|June 15, 2026
Parotid Oncocytomas Express the Glycoprotein Non-metastatic Melanoma Protein B (GPNMB): A Potential Link with Birt-Hogg-Dubé SyndromeAlberto Peraza-Labrador, Justin Bishop, Laura S Schmidt, et al.The Journal of Urology|December 13, 2002
A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladderEdward M Uchio, W Marston Linehan, William D Figg, et al.Pageof 51